Citations

Clear

3314 citation(s) found for "Do, Alexander".

Diffuse Alveolar Hemorrhage in Stem Cell Transplant Recipients
Zhang, Z., Wang, Chenxiao , Yadav, H., Niven, Alexander S.

Mayo Clinic

A44. CRITICAL CARE: ONE THOUSAND AND ONE NIGHTS - NON-PULMONARY CRITICAL CARE | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A1673-A1673

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1673 Get It

Pseudomonas Aeruginosa Associated with Severity of Non-Cystic Fibrosis Bronchiectasis Measured by the Modified Bronchiectasis Severity Score (BSI) and the FACED: The US Bronchiectasis and NTM Research Registry (BRR) Study
Aksamit, Timothy R. , Stone, Glenda , Barker, Alan F., Eden, Edward , DiMango, Angela, Fennelly, Kevin P. , Griffith, David E. , Johnson, Margaret M. , Knowles, Michael R. , McShane, Pamela J. , Noone, P.G., O’Donnell, Anne E., Olivier, K.N., Thomashow, Byron, Tino, Gregory , Winthrop, Kevin , O'Donnell, Anne E , Choate, Radmila , Mannino, David M. , Addrizzo‐Harris, Doreen , Basavaraj, Ashwin , Daley, Charles L. , Daniels, M. Leigh Anne , Metersky, Mark L. , Salathe, Matthias A. , Schmid, Andreas Alexander

Mayo Clinic

C105. BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5716-A5716

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5716 Get It

Beyond Young’s Syndrome: Diagnosis, Management, and Prognosis of Primary Ciliary Dyskinesia
Veerabattini, N., Niven, Alexander S.

Mayo Clinic

D43. COPD, CF, AND BRONCHIECTASIS CASE REPORTS | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A6451-A6451

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6451 Get It

How Do We Communicate with Our Critically Ill Patients? Interprofessional Perceptions and Practice
Valle, Katherine, Philbrick, Kemuel L. , Clark, Mike , Varga, Katalin , Karnatovskaia, Lioudmila V. , Valle, K. del, Niven, Alexander S.

Mayo Clinic

B106. CRITICAL CARE: A HUNDRED YEARS OF SOLITUDE - CARING FOR THE VULNERABLE: PATIENT, FAMILY, AND HCP-CENTERED CARE | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A4147-A4147

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4147 Get It

A Nebulous Cause of Hypercapneic Respiratory Failure with Systemic Lupus Erythematosus, Polymyositis, and Pneumonia
Heckman, Alexander , Burnside, R, Varma, Subhash, Colaco, Brendon, Varma, S.

Mayo Clinic

B40. AUTOIMMUNE LUNG DISEASE CASE REPORTS | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A3120-A3120

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3120 Get It

A Single Center Experience of Pneumonitis After Immune Checkpoint Inhibitor Therapy
Heckman, Alexander , Kwon, Minji , Arunthari, Vichaya, Lou, Yanyan , Grage, Rolf A. , Rojas, Carlos A. , Patel, Neal M. , Kwon, M., Manochakian, Rami

Mayo Clinic

D24. AUTOIMMUNE DISEASE, DRUG-INDUCED, AND TRANSPLANT | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5968-A5968

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5968 Get It

What about Serology? A Micro-Comic Strip
Theel, Elitza S. , McAdam, Alexander J.

Mayo Clinic

Journal of Clinical Microbiology | August 23, 2019 | Volume: 57 | Issue: 9 | Pages: No page available

10.1128/jcm.00797-19 | PMID 31451573 Get It

Impact of a Multidisciplinary eBoard on the Management of Patients With Complex Inflammatory Bowel Disease
Quinn, Kevin P. , Prothero, Breanne, Russell, Jennifer M. , Hegge, Ryan, Bormann, Alexander G. von, Larson, Putchalee, Christofferson, Sara, Smyrk, Thomas C. , Mathis, Kellie L. , Goenka, Ajit H. , Sheedy, Shannon P. , Bruining, David H. , Loftus, Edward V. , Raffals, Laura E. , Loftus, Edward V , Fletcher, Joel G.

Mayo Clinic

Crohn's & Colitis 360 | August 20, 2019 | Volume: 1 | Issue: 2 | Pages: No page available

10.1093/crocol/otz013 Get It

Abstract Background We aim to assess the impact of a multidisciplinary inflammatory bowel disease (IBD) conference on the management of patients with complex IBD. Methods Data were collected during each conference from February 2017 through October 2018 with chart review performed at 6 months to determine if conference recommendations were successfully implemented. Results Eighty-five patients were discussed. The presenting diagnosis was changed by 11.8%. Recommendations for further testing, medical therapy, and surgery were successfully implemented in 77.1%, 98.1%, and 88.4%, respectively. Conclusions This study supports the role of IBD multidisciplinary conferences in the management of patients with complex IBD.
Echo-Doppler Assessment of Left Filling Pressures in Adults With Repaired Tetralogy of Fallot
Miranda, William R. , Connolly, Heidi M. , Hagler, Donald J. , Oh, Jae K. , Egbe, Alexander C. , Taggart, Nathaniel W.

Mayo Clinic

Circulation: Cardiovascular Imaging | August 15, 2019 | Volume: 12 | Issue: 8 | Pages: No page available

10.1161/circimaging.119.009195 | PMID 31412722 Get It

ALG9 Mutation Carriers Develop Kidney and Liver Cysts
Besse, Whitney , Chang, Alex R. , Luo, Jonathan Z. , Triffo, William , Moore, Bryn S. , Gulati, Ashima , Hartzel, Dustin N. , Mane, Shrikant , Torres, Vicente E. , Somlo, Stefan , Torres, Vicente E , Chang, Alexander R , Mirshahi, Tooraj

Mayo Clinic

Journal of the American Society of Nephrology | August 8, 2019 | Volume: 30 | Issue: 11 | Pages: 2091-2102

10.1681/asn.2019030298 | PMID 31395617 Get It

Significance Statement Dominantly inherited polycystic kidney and liver phenotypes occur when epithelial cells in these organs have reduction of polycystin-1 functional dosage. In a cohort of genetically unresolved polycystic liver and kidney disease, the authors identified heterozygous loss of function mutations in ALG9 . ALG9 encodes an endoplasmic reticulum enzyme that builds N -glycans, and the authors show that Alg9 inactivation results in impaired polycystin-1 maturation. Using a novel ‘genotype-first’ approach to ascertain individuals based strictly on their ALG9 genotype from a large cohort of exome-sequenced individuals, the authors find that 7/8 (88%) of ALG9 mutation carriers over age 50 have multiple kidney cysts. Together, these findings identify ALG9 as a novel human polycystic kidney and liver disease gene and support the utility of a genotype-driven approach to candidate disease gene validation and genotype-phenotype correlation. Background Mutations in PKD1 or PKD2 cause typical autosomal dominant polycystic kidney disease (ADPKD), the most common monogenic kidney disease. Dominantly inherited polycystic kidney and liver diseases on the ADPKD spectrum are also caused by mutations in at least six other genes required for protein biogenesis in the endoplasmic reticulum, the loss of which results in defective production of the PKD1 gene product, the membrane protein polycystin-1 (PC1). Methods We used whole-exome sequencing in a cohort of 122 patients with genetically unresolved clinical diagnosis of ADPKD or polycystic liver disease to identify a candidate gene, ALG9 , and in vitro cell-based assays of PC1 protein maturation to functionally validate it. For further validation, we identified carriers of ALG9 loss-of-function mutations and noncarrier matched controls in a large exome-sequenced population-based cohort and evaluated the occurrence of polycystic phenotypes in both groups. Results Two patients in the clinically defined cohort had rare loss-of-function variants in ALG9 , which encodes a protein required for addition of specific mannose molecules to the assembling N-glycan precursors in the endoplasmic reticulum lumen. In vitro assays showed that inactivation of Alg9 results in impaired maturation and defective glycosylation of PC1. Seven of the eight (88%) cases selected from the population-based cohort based on ALG9 mutation carrier state who had abdominal imaging after age 50; seven (88%) had at least four kidney cysts, compared with none in matched controls without ALG9 mutations. Conclusions ALG9 is a novel disease gene in the genetically heterogeneous ADPKD spectrum. This study supports the utility of phenotype characterization in genetically-defined cohorts to validate novel disease genes, and provide much-needed genotype-phenotype correlations.